Skip to content
  • Home
  • About Us
  • Contact Us
  • Privacy policy
  • Terms of Service
  • Write For Us
  • Submit a Guest Post
  • Author Account
Market Encore
  • Business
  • Insurance
  • Investment
  • Stock Market
  • Finance
  • Loans
  • Taxes
  • Uncategorized
  • Home
  • About Us
  • Contact Us
  • Privacy policy
  • Terms of Service
  • Write For Us
  • Submit a Guest Post
  • Author Account
  • Riyadh Global Medical Biotechnology Summit 2026 Closes as a Major Success with SAR 5.5 Billion in Agreements and announcement, Confirming Saudi Arabia’s Commitment to Lead the Future of BiotechnologySeptember 17, 2026
    RIYADH, Saudi Arabia – The Riyadh Global Medical Biotechnology Summit closed today as a major success in its fourth edition and a clear statement of the scale of Saudi Arabia’s ambition in biotechnology. Over three days, more than 15,000 visitors...
  • RGMBS 2026 Life Sciences Innovation Forum Draws More Than USD 120 Million in Investor Interest as 23 Global Biotech Innovators Pitch in RiyadhSeptember 17, 2026
    RIYADH, Saudi Arabia – The Life Sciences Innovation Forum (LSIF), the investment platform of the Riyadh Global Medical Biotechnology Summit (RGMBS 2026), brought 23 biotechnology companies from eight countries to Riyadh to pitch to investors, judges, and leaders of the...
  • AtlasClear Holdings Reports Preliminary Fiscal 2026 Revenue of Approximately $20.1 Million, Up 85%; Revenue Plus Interest Income of Approximately $21.9 MillionSeptember 17, 2026
    TAMPA, Fla, September 17th, 2026, FinanceWire Stock Locate Fees Grow More Than 20-Fold to Approximately $6.8 Million; Commissions Up Approximately 56% Non-Commission Revenue Lines Now Represent Approximately 54% of Total Revenues, Up From 45% in Fiscal 2025 Second Consecutive Year...
  • AtlasClear Holdings Reports Preliminary Fiscal 2026 Revenue of Approximately $20.1 Million, Up 85%; Revenue Plus Interest Income of Approximately $21.9 MillionSeptember 17, 2026
    TAMPA, Fla, September 17th, 2026, FinanceWire Stock Locate Fees Grow More Than 20-Fold to Approximately $6.8 Million; Commissions Up Approximately 56% Non-Commission Revenue Lines Now Represent Approximately 54% of Total Revenues, Up From 45% in Fiscal 2025 Second Consecutive Year...
  • FET Earn: John Finser Brings AI , Dow Governance and Decentralized Trading TogetherSeptember 17, 2026
      London, United Kingdom — Artificial intelligence is rapidly changing the way people interact with technology, while blockchain continues to reshape how digital assets and financial applications are built. At the intersection of these two industries, a new approach to...

Latest Post

  • Riyadh Global Medical Biotechnology Summit 2026 Closes as a Major Success with SAR 5.5 Billion in Agreements and announcement, Confirming Saudi Arabia’s Commitment to Lead the Future of Biotechnology
    September 17, 2026
  • RGMBS 2026 Life Sciences Innovation Forum Draws More Than USD 120 Million in Investor Interest as 23 Global Biotech Innovators Pitch in Riyadh
    September 17, 2026
  • AtlasClear Holdings Reports Preliminary Fiscal 2026 Revenue of Approximately $20.1 Million, Up 85%; Revenue Plus Interest Income of Approximately $21.9 Million
    September 17, 2026
  • AtlasClear Holdings Reports Preliminary Fiscal 2026 Revenue of Approximately $20.1 Million, Up 85%; Revenue Plus Interest Income of Approximately $21.9 Million
    September 17, 2026
  • FET Earn: John Finser Brings AI , Dow Governance and Decentralized Trading Together
    September 17, 2026
© 2026 Market Encore - WordPress Theme by WPEnjoy